XDH and gout: These findings consistently highlight that combination therapies involving both a xanthine oxidase inhibitor (XOI) and uricosuric agents yield significantly greater reductions in serum urate levels compared to the urate-lowering effects achievable through monotherapy in acute gout treatment.